XML 12 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues $ 384,014 $ 378,734 $ 1,134,823 $ 1,142,800
Cost of goods sold 161,648 136,608 433,746 403,054
Gross profit 222,366 242,126 701,077 739,746
Operating expenses        
Sales and marketing 48,828 43,719 132,372 134,300
General and administrative 81,898 40,516 205,229 135,820
Research and development 48,025 24,148 129,828 132,773
Total operating expenses 178,751 108,383 467,429 402,893
Gain on sale of assets 0 0 0 6,254
Operating income 43,615 133,743 233,648 343,107
Interest expense 4,950 4,903 14,671 14,624
Investment in equity securities - unrealized gain (1,160) (37,325) (871) (75,492)
Other income (2,556) (9,953) (23,579) (27,785)
Income before income taxes 42,381 176,118 243,427 431,760
Income tax expense 14,610 45,025 63,956 107,528
Net income $ 27,771 $ 131,093 $ 179,471 $ 324,232
Net income per common share:        
Basic (in dollars per share) $ 0.41 $ 1.89 $ 2.63 $ 4.69
Diluted (in dollars per share) $ 0.41 $ 1.79 $ 2.6 $ 4.55
Weighted-average common shares outstanding:        
Basic (in shares) 67,230 69,464 68,132 69,193
Diluted (in shares) 67,663 73,065 69,038 71,331